We have previously reported that IFN-α induces IL-6 in human RCC cell lines and that IL-6 plays a crucial role for resistance also against IFN-α treatment through suppressed STAT1 phosphorylation and induced phosphorylation of STAT3 and ERK [19]. The gene discussed is STAT3; the disease is renal cell carcinoma.